Effects of a New Conjugate Drug in a Rat Model of Postmenopausal Osteoporosis

Effects of a New Conjugate Drug in a Rat Model of Postmenopausal Osteoporosis

Show other versions (1)

Postmenopausal osteoporosis is a disease characterized by bone loss and increased risk of fracture, and represents a significant burden on the Canadian health care system. Current treatments lack the ability to simultaneously address the therapeutic needs for promoting bone formation and inhibiting...

Full description

Bibliographic Details
Main Author:	Liu, Careesa Chang
Other Authors:	Grynpas, Marc D.
Language:	en_ca
Published:	2013
Subjects:	osteoporosis treatment bone formation anabolic conjugate OVX ovariectomized rat in vivo endocortical prodrug dual-acting EP4 agonist alendronate intracortical remodeling trabecular prostaglandin E2 0541
Online Access:	http://hdl.handle.net/1807/43088

Similar Items

Effects of a New Conjugate Drug in a Rat Model of Postmenopausal Osteoporosis
by: Liu, Careesa Chang
Published: (2013)

Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis
by: Wang Y, et al.
Published: (2019-09-01)

3,3′-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice
by: Tai-yong Yu, et al.
Published: (2015-01-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Effects of short- and long-term glucocorticoid-induced osteoporosis on plasma metabolome and lipidome of ovariectomized sheep
by: Diana Cabrera, et al.
Published: (2020-06-01)

Effect of Short-Term Estrogen Depletion on Compact Bone Microdensitometry in the Ewe
by: Bugbee, Cailyn
Published: (2012)

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study
by: Mohammad Hassan Jokar, et al.
Published: (2016-01-01)

Kefir Peptides Prevent Estrogen Deficiency-Induced Bone Loss and Modulate the Structure of the Gut Microbiota in Ovariectomized Mice
by: Min-Yu Tu, et al.
Published: (2020-11-01)

Anti-Osteoporotic Effects of the Herbal Mixture of <i>Cornus officinalis</i> and <i>Achyranthes japonica</i> In Vitro and In Vivo
by: Eunkuk Park, et al.
Published: (2020-08-01)

Effect of shaking and vibration stimulation on lumbar vertebrae in ovariectomized mice
by: Takumi Kito, et al.
Published: (2019-08-01)

Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis
by: Yunyun Di, et al.
Published: (2021-06-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

BONE MARKERS IN MONITORING OF ANTIRESORPTIVE THERAPY IN POSTMENOPAUSAL OSTEOPOROSIS PATIENTS
by: Tanja Džopalić, et al.
Published: (2015-09-01)

OSTEOPOROSIS: A VIEW OF THE PROBLEM OF DIAGNOSIS AND TREATMENT
by: Nataliya Vladimirovna Toroptsova
Published: (2009-09-01)

Expression Profile Analysis of Long Non-coding RNA in OVX Models-Derived BMSCs for Postmenopausal Osteoporosis by RNA Sequencing and Bioinformatics
by: Huijie Gu, et al.
Published: (2021-09-01)

A case of atypical femur fracture during long-term treatment with bisphosphonates in patient with postmenopausal osteoporosis
by: Kira E. Zotkina, et al.
Published: (2019-11-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Effects of Ovariectomy, Seasonal Changes, and Anatomical Position on the Compact Bone Remodeling as seen in the Adult Ovine Model
by: Wong, Erica
Published: (2012)

Dietary Natural N-Acetyl-d-Glucosamine Prevents Bone Loss in Ovariectomized Rat Model of Postmenopausal Osteoporosis
by: Zhiwen Jiang, et al.
Published: (2018-09-01)

Economic Evaluation of Oral Alendronate Therapy for Osteoporosis in Chinese Postmenopausal Women: The Impact of Medication Compliance and Persistence
by: Ruxu You, et al.
Published: (2020-11-01)

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01)

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

Duration of treatment for osteoporosis
by: Luca Idolazzi, et al.
Published: (2013-03-01)

Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01)

Osteoporosis and its complications: treatment adherence and possibilities of its enhancement
by: O V Dobrovol'skaya, et al.
Published: (2011-09-01)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis
by: Antonino Catalano, et al.
Published: (2021-05-01)

Osteoanabolics
by: Vishal Gupta, et al.
Published: (2012-01-01)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation
by: Levent Ediz, et al.
Published: (2010-04-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Preventive Effects of Eleutherococcus senticosus Bark Extract in OVX-Induced Osteoporosis in Rats
by: Yun Tai Kim, et al.
Published: (2013-07-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
by: Fatemeh Khanizadeh, et al.

Rheumatoid arthritis, osteoporosis, possibilities for the correction of bone mineral density
by: Rimma Mikhailovna Balabanova
Published: (2012-09-01)

Cannot write session to /tmp/vufind_sessions/sess_u41dqd43oi1hilvmps2r27pn9t